Drug intelligence / Profile preview

epidermal growth factor + basic fibroblast growth factor + stem cell therapy

Development stage: Preclinical
Lead developer: Uni-Bio Science Group
Modality: Recombinant Proteins and Enzymes, Drug Delivery Systems, Stem Cell Therapies → Cell Therapies
Administration: Intraarticular, Local Injection

Overview

A regenerative musculoskeletal program developed by Uni-Bio Science that utilizes a combination of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and stem cell-related therapies. This multi-modal approach is designed to promote tissue, bone, and cartilage repair by leveraging the synergistic effects of growth factor signaling and cellular regeneration. The program incorporates biomaterials to support the delivery and integration of these components. It is primarily targeted at treating conditions such as osteoporosis, bone fractures, cartilage damage, and arthritis, aiming to accelerate healing and restore structural integrity to damaged musculoskeletal tissues.

Other names: EGF/bFGF/stem cellUni-Bio Science regenerative musculoskeletal program

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)FGFR (FGFR family)

Beyond the preview

Go deeper on epidermal growth factor + basic fibroblast growth factor + stem cell therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on epidermal growth factor + basic fibroblast growth factor + stem cell therapy.

Explore the full profile